Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population.

Kumari R, Lakhan R, Garg RK, Kalita J, Misra UK, Mittal B.

Indian J Hum Genet. 2011 May;17 Suppl 1:S32-40. doi: 10.4103/0971-6866.80357.

PMID:
21747585
[PubMed]
Free PMC Article
2.

ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.

Haerian BS, Roslan H, Raymond AA, Tan CT, Lim KS, Zulkifli SZ, Mohamed EH, Tan HJ, Mohamed Z.

Seizure. 2010 Jul;19(6):339-46. doi: 10.1016/j.seizure.2010.05.004. Epub 2010 Jun 3. Review.

PMID:
20605481
[PubMed - indexed for MEDLINE]
Free Article
3.

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

Staatz CE, Goodman LK, Tett SE.

Clin Pharmacokinet. 2010 Mar;49(3):141-75. doi: 10.2165/11317350-000000000-00000. Review.

PMID:
20170205
[PubMed - indexed for MEDLINE]
4.

Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies.

Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MÁ, Aliño SF.

Pharmacogenomics J. 2015 Jan 6. doi: 10.1038/tpj.2014.80. [Epub ahead of print] Review.

PMID:
25558979
[PubMed - as supplied by publisher]
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk